![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://chemrxiv.org/engage/assets/public/chemrxiv/images/logos/orcid.png)
Abstract
In this study, a research strategy combining network pharmacological analysis, protein docking and molecular docking virtual computation was adopted. It was found that phillyrin and chlorogenic acid could block the combination of 2019-nCoV S-protein and ACE2 at the molecular level. Both can be used as potential inhibitors of 2019-nCoV for further research and development.
Supplementary materials
Title
Schedule 1
Description
Actions
Title
Schedule 1
Description
Actions
Title
Schedule 3
Description
Actions
Title
Schedule 2
Description
Actions
Title
Schedule 1
Description
Actions
Title
Schedule 1
Description
Actions
Title
Fig 6
Description
Actions
Title
fig5
Description
Actions
Title
fig4
Description
Actions
Title
fig3
Description
Actions
Title
fig2
Description
Actions
Title
fig 1
Description
Actions
